Tonix Pharmaceuticals announced it will present its investigational TNX-801 vaccine, based on horsepox virus, at the World Vaccine Congress Europe in Amsterdam from October 19-21, 2026. TNX-801 is a live, attenuated vaccine in pre-clinical development aimed at preventing mpox, smallpox, and other infectious diseases, with a Phase 1 trial planned for 2027 pending FDA approval. The company will also lead a working group session on vectored vaccine platforms to discuss design and efficacy improvements. This highlights Tonix's ongoing efforts to advance its infectious disease pipeline alongside its CNS disorder treatments.
Tonix Pharmaceuticals' vaccine presentation news provides context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 15, 2026 17:42 WIB: Out of 150 priced US health-sector stocks, 93 rose and 47 fell. Notable movers include IBRX at USD 10.20 with a 1-day change of +2.93% and a typical hold time of 6 days; TWST at USD 144.00 with a 1-day change of -2.81% and Pluang order activity of 51% Sell / 49% Buy; and AZN at USD 166.41 with a 1-day change of +2.70% and Pluang order activity of 41% Sell / 59% Buy, typical hold time 126 days.
The Saudi Arabia Non-Invasive Prenatal Testing (NIPT) market is projected to grow from $52.5 million in 2025 to $162.16 million by 2034, at a CAGR of 13.35%. Growth is fueled by rising maternal age, advances in molecular diagnostics, and increased he...
TiDB, powered by PingCAP, announced new cloud platform capabilities to support enterprise and AI applications on a unified data foundation. Key updates include the upcoming general availability of TiDB Cloud Premium, public previews of Bring Your Own...
Alcoa will release its Q3 2026 earnings on October 15, with analysts divided on earnings per share and revenue forecasts due to factors like rising aluminum sales, inventory changes, and higher input costs. The company expects a 54.9% jump in aluminu...
Nokia has transferred 2,142,361 of its own shares to employees participating in its stock-based incentive programs, as per a board decision announced in October 2025. This transfer was made without compensation and is part of fulfilling commitments u...
Pallavi Mahajan, a senior manager at Nokia Corporation, received 35,192 shares through a share-based incentive on October 15, 2026. This transaction was reported under EU Market Abuse Regulation, reflecting Nokia's ongoing use of equity incentives to...
